UGT1A4*3 Encodes Significantly Increased Glucuronidation of Olanzapine in Patients on Maintenance Treatment and in Recombinant Systems

The relationship between UGT1A4 polymorphism and serum concentration of lamotrigine in patients with epilepsy

(2011) Medine Idrizoglu Gulcebi et al.   EPILEPSY RESEARCH

Olanzapine metabolism and the significance of UGT1A448V and UGT2B1067Y variants

(2011) Kathryn Kelly Erickson-Ridout et al.   Pharmacogenetics and Genomics

AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011

(2011) C. Hiemke et al.   PHARMACOPSYCHIATRY

Carriers of the UGT1A4 142T>G gene variant are predisposed to reduced olanzapine exposure—an impact similar to male gender or smoking in schizophrenic patients

(2010) Roza Ghotbi et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Influence of N-Terminal Domain Histidine and Proline Residues on the Substrate Selectivities of Human UDP-Glucuronosyltransferase 1A1, 1A6, 1A9, 2B7, and 2B10

(2009) O. Kerdpin et al.   DRUG METABOLISM AND DISPOSITION

Insights on membrane topology and structure/function of UDP-glucuronosyltransferases

(2009) Jacques Magdalou et al.   DRUG METABOLISM REVIEWS